Coeptis Therapeutics Holdings, Inc. Warrants (COEPW)

• Market cap: $67.4K
• 1 day: 0.00%
• 5 days: 6.35%
• 1 month: 448.28%
• 3 months: 38.86%
• 6 months: 59.00%
• Year to date: -11.17%
• 1 year: 50.71%
• 5 years: -94.70%
• 10 years: -94.70%
• Sector: Healthcare
• Industry: Biotechnology

About: Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Employees: 7

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

2.11% less ownership

Funds ownership: 4.47% [Q3] → 2.36% (-2.11%) [Q4]

24% less capital invested

Capital invested by funds: $27.4K [Q3] → $20.8K (-$6.61K) [Q4]

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

29% less funds holding

Funds holding: 17 [Q3] → 12 (-5) [Q4]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4